We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Fractionated Radiotherapy Improves Cancer Surgery Results

By HospiMedica International staff writers
Posted on 23 Feb 2017
Short-course preoperative radiotherapy (RT) combined with delayed surgery reduces the adverse side effects of rectal cancer surgery, according to a new study.

Researchers at Karolinska Institutet, Uppsala University, and other institutions conducted a phase 3 non-inferiority trial involving 840 patients from 18 Swedish hospitals who were randomized to three different RT regimens, with respect to fractionation and time to surgery. More...
All patients suffered from biopsy-proven adenocarcinoma of the rectum, without signs of non-resectability or distant metastases, without severe cardiovascular comorbidity, and with planned abdominal resection.

The participants were randomly assigned with permuted blocks, stratified by participating center, to receive either 5 × 5 Gy radiation dose with surgery within one week (short-course radiotherapy), or after 4–8 weeks (short-course radiotherapy with delay), or 25 × 2 Gy radiation dose with surgery after 4–8 weeks (long-course radiotherapy with delay). The primary endpoint was time to local recurrence, as calculated from the date of randomization to the date of local recurrence.

The results showed that in patients with any local recurrence, median time from date of randomization to local recurrence in the short-course RT comparison was 33.4 months; in the short-course RT group, it was 19.3 months; and in the long-course RT with delay group it was 33.3 months. Postoperative complications were similar between all three arms; however, the risk of postoperative complications was significantly lower after short-course RT with delay. The study was published on February 9, 2017, in The Lancet Oncology.

“The results of the study will give rise to improved therapeutic strategies, fewer complications with a sustained low incidence of local recurrence, and better survival rates for rectal cancer patients,” said senior author Professor Anna Martling, PhD, of the KI department of molecular medicine and surgery. “It also showed that there is no difference between long-course and short-course radiotherapy, other than that the former considerably lengthens the time for treatment.”

When the total dose of radiation is fractionated into several, smaller doses over a period of several days, there are fewer toxic effects on healthy cells. Typical fractionation schemes divide the radiation dose into units delivered every weekday over about six weeks. The logic behind the treatment is that applying greater amounts of radiation works to lower the effects of accelerated tumor growth that typically occurs during the later stages of RT.


Gold Member
12-Channel ECG
CM1200B
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Gas Analyzer
GE SAM
Hypodermic Syringe
SurTract™ Safety Syringe
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.